Further analysis of these DEGs showed that Eph receptor B2 (EphB2), involved in the inhibition of T cell activity, SRY-box transcription factor 11 (SOX11), and tripartite motif containing 59 (TRIM59), which promotes MSC differentiation, were associated with the outcomes of GVHD treated by MSCs. This evidence concerns the gene EPHB2 and graft versus host disease.